MktsMarkets

BioRestorative Therapies, Inc.
NASDAQ: BRTXKey statistics
BRTX News
Stories mentioning BRTX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 23.00 | 20.00 | 12.00 | 303.00 | 25.00 | 43.00 | 234.00 | 89.00 |
| Cost of Goods Sold | 7.00 | 1.00 | 11.00 | 9.00 | 3.00 | 18.00 | 6.00 | |
| Gross Profit | 16.00 | 18.00 | 1.00 | 295.00 | 22.00 | 40.00 | 215.00 | 83.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,926 | 2,627 | 2,595 | 2,226 | 2,647 | 2,742 | 1,453 | 1,454 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,402 | 3,843 | 3,710 | 3,600 | 4,830 | 2,731 | 2,502 | 2,551 |
| Operating Income (Loss) | (3,386) | (3,825) | (3,709) | (3,305) | (4,808) | (2,690) | (2,287) | (2,469) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 6.00 | 14.00 | 1.00 | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,154) | (3,208) | (3,038) | (2,656) | (5,340) | (1,636) | (1,091) | (4,029) |
| Earnings Per Share (Basic) | (0.12) | (0.36) | (0.33) | (0.30) | (0.64) | (0.21) | (0.13) | (0.50) |
| Earnings Per Share (Diluted) | (0.12) | (0.36) | (0.33) | (0.30) | (0.64) | (0.21) | (0.13) | (0.50) |
| Weighted Average Shares Outstanding (Basic) | 17,728 | 8,993 | 9,116 | 8,740 | 8,357 | 7,764 | 8,121 | 8,121 |
| Weighted Average Shares Outstanding (Diluted) | 17,728 | 8,993 | 9,116 | 8,740 | 8,357 | 7,764 | 8,121 | 8,121 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BRTX
BioRestorative Therapies, Inc. (NASDAQ: BRTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BRTX. It last traded at $1.37 (Nov 18, 2026, 2:25 PM ET), up 2.2% on the day. That gives BioRestorative Therapies a market capitalisation of $1.9M.
Over the past 52 weeks BRTX has traded between $1.28 and $28.99.
Revenue for the quarter ended Mar 31, 2026 was $23.0K; a net loss of $2.2M. Revenue was down 8.0% from $25.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $23.0K | -$2.2M | -9365.2% |
| Dec 31, 2025 | $20.0K | -$3.2M | -16040.0% |
| Sep 30, 2025 | $12.0K | -$3.0M | -25316.7% |
| Jun 30, 2025 | $303.0K | -$2.7M | -876.6% |
From BioRestorative Therapies’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…